Video guest: Josephine Mwangi

March 2018
26 27 28 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1



Follow the CTA Brussels Daily


twitter logo


facebook logo cta

Thursday, 07 April 2011

New strategy needed to stop tuberculosis reoccurring in poorer patients

The standard approach to re-treating tuberculosis (TB) in low and middle income settings is failing, according to new research. In a study published in the journal PLoS Medicine, scientists call for improved access to rapid diagnostics for drug-resistant TB, second—line TB treatment and antiretroviral HIV (human immunodeficiency virus) therapy. They point out that each year, between 1 in 10 and 1 in 5 patients treated for TB see their disease return after failing, interrupting or relapsing from treatment. The aim of this study, by researchers in South Africa, Uganda, the UK and the US, was to investigate treatment and survival outcomes in patients who had been treated for TB in the past and identify the factors associated with poor treatment outcomes. The findings highlight the need for more effective strategies to treat people with recurring TB.

Source: European Commission